Session Details

F081 Botulinum Toxins: The Latest Updates

Sun, Mar 10, 1:00 PM - 3:00 PM
Room 20A
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Botulinum Toxin use has advanced significantly since its introduction in aesthetics. There are currently multiple choices of BNTA products and evolving indications and uses. This forum aims to examine where we came from and what is new in understanding our clinical use of neuromodulators. We will present data on the similarities and differences in those drugs both available and soon to be available, as well as repeated dosing and their influences on outcome. New uses and anatomy related to injection technique will also be discussed.

LEARNING OBJECTIVES

1.

Discriminate between the various neuromodulators on the market

2.

Determine ideal injection locations and anatomic safety zones to obtain the maximum efficacy

3.

Outline the future of neuromodulators, including new indications and new products

SPEAKERS

Andre Vieira Braz, MD

Andre Vieira Braz, MD

Mitchell F. Brin, MD

Mitchell F. Brin, MD

Jean D.A. Carruthers, MD

Jean D.A. Carruthers, MD

Doris M Hexsel, MD, IFAAD

Doris M Hexsel, MD, IFAAD

Joely Kaufman, MD, FAAD

Joely Kaufman, MD, FAAD

SPEAKER DISCLOSURES

Andre Vieira Braz, MD

Allergan, Inc – Speaker(Honoraria);

Mitchell F. Brin, MD

AbbVie – Employee (w-2 relationship)(Salary), Employee (w-2 relationship)(Stock);

Jean D.A. Carruthers, MD

Alastin Skincare, Inc – Consultant(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Investigator(Grants/Research Funding); Bonti – Consultant(No Compensation Received); Fount Bio – Consultant (1099 relationship)(No Compensation Received); In Mode – Consultant (1099 relationship)(Grants/Research Funding); Kythera – Consultant(Honoraria); Kythera Biopharmaceuticals – Investigator(Honoraria); Merz Aesthetics – Consultant(Honoraria), Investigator(Honoraria); Revance Therapeutics, Inc. – Investigator(Honoraria);

Doris M Hexsel, MD, IFAAD

No financial relationships exist with ineligible companies.

Joely Kaufman, MD, FAAD

Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Alphaeon – Stockholder(No Compensation Received); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Johnson and Johnson – Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Investigator(Grants/Research Funding); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Fees);